GoodRx Holdings

History

2020: Entry into the exchange

At the end of September, 2020 the telemedicine company GoodRx Holdings which helps consumers to find prescription drugs and other medical care at low prices went public and attracted more than $1 billion during initial public offering. During trading the share price almost for 18% exceeded the upper bound of initially stated range.

GoodRx intends to use proceeds for the general corporate purchases, including for acquisition of new business divisions. So, in 2019 GoodRx purchased service provider of telemedicine of HeyDoctor for $14.3 million, and in 2020 independently began to provide telemedicine services.

The telemedicine company GoodRx went public $20 billion with capitalization

Our data show that about 20% of consumers who look for drugs on GoodRx did not receive the recipe at the time of search yet. Using HeyDoctor and GoodRx Telehealth Marketplace we can provide to these and other consumers a convenient and available method to receive the diagnosis and the recipe online, where appropriate from the medical point of view.

GoodRx sold about 34.6 million shares at the IPO price to attract $1.14 billion. The company also sold shares of a class A for $100 million GoodRx it is considered the controlled company because of large investors among whom it is possible to note Francisco Partners, Spectrum and Idea Men. In total these investors have more than 90% of voices in the company.

The company will receive sales proceeds about 23.4 million shares, i.e. about $772 million and also from private placement. The rest will be received by sellers shareholders. The underwriters headed by Morgan Stanley, Goldman Sachs, JPMorgan and Barclays will receive additional 5.2 million shares of the company. Within the same offer employees and directors of the company sell the shares Spectrum and Idea Men and also.^[1]

Notes